ADRIAMYCIN-INDUCED DELAYED ERYTHROPOIETIC INJURY EXPRESSED FOLLOWING ANEMIA STRESS

Authors:
  • PBP G Braunschweiger
    P G Braunschweiger
  • LSL L Schenken
    L L Schenken
  • LSL M Schiffer
    L M Schiffer

  • 1 January 1980
    • journal article
    • research article
    • Vol. 40  (7) , 2257-2262
    • PMID:7388791
Abstract
Anemia-induced erythropoietic responses in femoral marrows and spleens of mice pretreated with adriamycin (ADR) or 1-.beta.-D-arabinofuranosylcytosine [both antineoplastic drugs] were compared with those of untreated age-matched controls. Mice were bled 45 or 120 days after drug treatment. The erythropoietic response to bleeding was quantitated by morphological, gravimetric and radioiron methods 48 h after bleeding. At 120 days after ADR, prebleeding base-line cellularity parameters were, in general, similar to those found in untreated age-matched controls. The response to the anemia stress was compared in drug-treated animals and in age-matched untreated controls; the response deficit was expressed as residual injury (RI). At 120 days, ADR-induced RI was dose-dependent in femoral marrow and spleen. ADR-induced RI in femoral marrow and spleen were similar at 45 and 120 days, with no significant recovery. Although marrow RI was noted 45 days after 200 mg 1-.beta.-D-arabinofuranosylcytosine/kg, there was no RI at 120 days. ADR apparently can induce a long-lasting hematopoietic injury which is not obvious from measures of homeostatic cellularity, but which can be expressed after induction of an acute proliferative demand.